Rui-Yan Zhang1, Wen-Qi Du1, Ying-Chun Zhang1, Jun-Nian Zheng2,3,4, Dong-Sheng Pei5. 1. Jiangsu Key Laboratory of Biological Cancer Therapy, Xuzhou Medical College, 84 West Huai-hai Road, Xuzhou, 221002, Jiangsu, People's Republic of China. 2. Jiangsu Key Laboratory of Biological Cancer Therapy, Xuzhou Medical College, 84 West Huai-hai Road, Xuzhou, 221002, Jiangsu, People's Republic of China. jnzheng@xzmc.edu.cn. 3. Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical College, Xuzhou, 221002, People's Republic of China. jnzheng@xzmc.edu.cn. 4. Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical College, Xuzhou, 221002, Jiangsu, People's Republic of China. jnzheng@xzmc.edu.cn. 5. Jiangsu Key Laboratory of Biological Cancer Therapy, Xuzhou Medical College, 84 West Huai-hai Road, Xuzhou, 221002, Jiangsu, People's Republic of China. dspei@xzmc.edu.cn.
Abstract
PURPOSE: As one of the members of the PLC family, the phosphoinositide-specific phospholipase Cε (PLCε) has been shown to play pivotal roles in multiple signal pathways and control a variety of cellular functions. A number of studies have shown that aberrant regulation of PLCε was involved in various types of animal and human cancer. However, the role of PLCε in cancer remains elusive. In this review, we provide an overview of the PLCε, especially its roles in multiple signal pathways, and summarize the recent findings that highlight the roles of PLCε in carcinogenesis and cancer progression, making an avenue to provide a novel therapeutic strategy for the treatment of cancer. METHODS: A literature search mainly paying attention to the network of PLCε involved in tumorigenesis and development was performed in electronic databases. RESULTS: PLCε plays a key role in medicating the development and progression of human cancers with highest potency to be a target of cancer prevention and treatment.
PURPOSE: As one of the members of the PLC family, the phosphoinositide-specific phospholipase Cε (PLCε) has been shown to play pivotal roles in multiple signal pathways and control a variety of cellular functions. A number of studies have shown that aberrant regulation of PLCε was involved in various types of animal and humancancer. However, the role of PLCε in cancer remains elusive. In this review, we provide an overview of the PLCε, especially its roles in multiple signal pathways, and summarize the recent findings that highlight the roles of PLCε in carcinogenesis and cancer progression, making an avenue to provide a novel therapeutic strategy for the treatment of cancer. METHODS: A literature search mainly paying attention to the network of PLCε involved in tumorigenesis and development was performed in electronic databases. RESULTS: PLCε plays a key role in medicating the development and progression of humancancers with highest potency to be a target of cancer prevention and treatment.
Entities:
Keywords:
Cancer; EGFR; NF-κB; Phospholipase Cε; Ras; Signal pathway
Authors: Diane Palmieri; Amina Bouadis; Ruban Ronchetti; Maria J Merino; Patricia S Steeg Journal: Breast Cancer Res Treat Date: 2006-06-22 Impact factor: 4.872
Authors: Lianghui Zhang; Sundeep Malik; Jinjiang Pang; Huan Wang; Keigan M Park; David I Yule; Burns C Blaxall; Alan V Smrcka Journal: Cell Date: 2013-03-28 Impact factor: 41.582
Authors: Guobin He; Guann-Yi Yu; Vladislav Temkin; Hisanobu Ogata; Christian Kuntzen; Toshiharu Sakurai; Wolfgang Sieghart; Markus Peck-Radosavljevic; Hyam L Leffert; Michael Karin Journal: Cancer Cell Date: 2010-03-16 Impact factor: 31.743